Russell D Cohen

Russell D Cohen

UNVERIFIED PROFILE

Are you Russell D Cohen?   Register this Author

Register author
Russell D Cohen

Russell D Cohen

Publications by authors named "Russell D Cohen"

Are you Russell D Cohen?   Register this Author

92Publications

1540Reads

28Profile Views

The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data.

J Crohns Colitis 2020 Feb;14(2):192-204

Translational Gastroenterology Unit, National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjz137DOI Listing
February 2020

Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.

Dig Dis Sci 2019 Dec 11;64(12):3596-3601. Epub 2019 Jun 11.

University of Chicago Medicine, Inflammatory Bowel Disease Center, 5841 S. Maryland Ave, MC 4076, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-019-05697-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858501PMC
December 2019

Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.

J Crohns Colitis 2019 Sep;13(9):1105-1110

Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjz032DOI Listing
September 2019

Follow-Up of Patients With Ulcerative Colitis and Histological Normalization.

Clin Gastroenterol Hepatol 2019 Jun 20. Epub 2019 Jun 20.

Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.06.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923607PMC
June 2019

Maneuvering Clinical Pathways for Crohn's Disease.

Curr Gastroenterol Rep 2019 Apr 23;21(5):20. Epub 2019 Apr 23.

Section of Gastroenterology, Hepatology and Nutrition, Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11894-019-0687-4DOI Listing
April 2019

Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.

Clin Gastroenterol Hepatol 2019 02 8;17(3):486-493. Epub 2018 May 8.

Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.04.060DOI Listing
February 2019

Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.

Clin Gastroenterol Hepatol 2019 01 8;17(1):205-206. Epub 2018 May 8.

Inflammatory Bowel Disease Center, Department of Medicine, Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago Medicine, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.04.061DOI Listing
January 2019

Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies.

J Immunother Cancer 2019 01 6;7(1). Epub 2019 Jan 6.

Department of Medicine, University of Chicago, 5841 S. Maryland Ave. MC2115, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-018-0484-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322234PMC
January 2019

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.

Am J Gastroenterol 2018 11 19;113(11):1678-1688. Epub 2018 Jul 19.

Department of Medicine, Division of Gastroenterology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Robarts Clinical Trials, Western University, London, ON, Canada. University of California, San Francisco, CA, USA. Atlanta Gastroenterology Specialists, Atlanta, GA, USA. Janssen Research & Development, LLC, Spring House, PA, USA. Formerly an employee of Janssen Scientific Affairs, LLC, Horsham, PA, USA. Janssen-Cilag Oy, Espoo, Finland. Formerly an employee of Janssen Biologics BV, Leiden, The Netherlands. Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA. Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, Chicago, IL, USA. Some of the data in this article were presented at United European Gastroenterology Week 2013 in Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41395-018-0202-9DOI Listing
November 2018

Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.

J Clin Gastroenterol 2018 07;52(6):537-544

Department of Medicine, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000000889DOI Listing
July 2018

Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.

Gastrointest Endosc 2018 May 4;87(5):1304-1309. Epub 2018 Jan 4.

Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gie.2017.12.016DOI Listing
May 2018

Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.

Dig Dis Sci 2018 May 22;63(5):1294-1301. Epub 2018 Feb 22.

Inflammatory Bowel Disease Center, University of Chicago Medicine, 5841 S. Maryland Ave. | MC4076|, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10620-018-4980-0
Publisher Site
http://dx.doi.org/10.1007/s10620-018-4980-0DOI Listing
May 2018

Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience.

Inflamm Bowel Dis 2018 02;24(3):490-501

Division of Gastroenterology, University of California San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izx072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176880PMC
February 2018

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.

Clin Gastroenterol Hepatol 2018 Jan 1;16(1):99-105. Epub 2017 Sep 1.

Division of Gastroenterology, University of California-San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2017.08.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735029PMC
January 2018

Nonmedical Switching of Biosimilars in Patients With Inflammatory Bowel Disease.

Authors:
Russell D Cohen

Gastroenterol Hepatol (N Y) 2017 Nov;13(11):697-699

Professor of Medicine, Pritzker School of Medicine Director, Inflammatory Bowel Disease Center The University of Chicago Medicine Chicago, Illinois.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717886PMC
November 2017

Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease.

PLoS One 2017 24;12(8):e0182900. Epub 2017 Aug 24.

Department of Internal Medicine, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182900PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570509PMC
October 2017

Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.

Am J Gastroenterol 2017 Sep 18;112(9):1423-1429. Epub 2017 Jul 18.

Section of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.201DOI Listing
September 2017

Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.

Inflamm Bowel Dis 2016 May;22(5):1027-31

Inflammatory Bowel Disease Center, University of Chicago Medical Center, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000732DOI Listing
May 2016

Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.

Inflamm Bowel Dis 2016 Mar;22(3):631-7

*University of Chicago Inflammatory Bowel Disease Center, Chicago, Illinois; †Northwestern University Feinberg School of Medicine; and ‡Department of Pathology, University of Chicago.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ibdjournal/2016/03000/Surveilla
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058785PMC
http://dx.doi.org/10.1097/MIB.0000000000000634DOI Listing
March 2016

Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy.

Clin Gastroenterol Hepatol 2015 Nov 19;13(11):1919-25. Epub 2015 May 19.

Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2015.05.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795937PMC
November 2015

What to Do When Biologic Agents Are Not Working in Inflammatory Bowel Disease Patients.

Gastroenterol Hepatol (N Y) 2015 Oct;11(10):657-65

Dr Dalal is an assistant professor of medicine in the Section of Gastroenterology and Dr Cohen is a professor of medicine and director of the Inflammatory Bowel Disease Center at The University of Chicago Medicine in Chicago, Illinois.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849518PMC
October 2015

Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis.

Inflamm Bowel Dis 2015 Jul;21(7):1719-36

Section of Gastroenterology, The University of Chicago Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000379DOI Listing
July 2015

Ulcerative Colitis Care Pathway.

Gastroenterology 2015 Jul 27;149(1):238-45. Epub 2015 May 27.

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.05.036DOI Listing
July 2015

Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease.

Inflamm Bowel Dis 2014 Oct;20(10):1722-8

Section of Gastroenterology, Hepatology, and Nutrition, Department of Inflammatory Bowel Disease, The University of Chicago Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ibdjournal/2014/10000/Incidence
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MIB.0000000000000146DOI Listing
October 2014

Dietary fiber intake and Crohn's disease.

Gastroenterology 2014 Apr 24;146(4):1133. Epub 2014 Feb 24.

Department of Medicine, Pritzker School of Medicine and Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.12.044DOI Listing
April 2014

Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.

Am J Gastroenterol 2014 Feb 7;109(2):212-23. Epub 2014 Jan 7.

Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2013.441DOI Listing
February 2014

Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.

Clin Gastroenterol Hepatol 2013 Dec 17;11(12):1601-8.e1-4. Epub 2013 Jul 17.

Department of Medicine, University of Chicago Medical Center, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2013.06.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840031PMC
December 2013

The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapies.

Inflamm Bowel Dis 2013 Dec;19(13):2778-86

*IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel; †Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; ‡Inflammatory Bowel Disease Center, University of Chicago Medical Center, Chicago, Illinois; and §Gastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

View Article

Download full-text PDF

Source
https://academic.oup.com/ibdjournal/article/19/13/2778-2786/
Publisher Site
http://dx.doi.org/10.1097/01.MIB.0000435435.91988.b6DOI Listing
December 2013

Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.

Inflamm Bowel Dis 2013 Nov;19(12):2577-83

Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0b013e3182a8df32DOI Listing
November 2013

Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis.

J Manag Care Pharm 2012 Nov-Dec;18(9):701-12

Global Health Economics and Outcomes Research, Shire Development LLC, 725 Chesterbrook Blvd., Wayne, PA 19087, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2012.18.9.701DOI Listing
May 2013

Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.

Inflamm Bowel Dis 2013 Mar;19(3):621-6

Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0b013e31827eea78DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779049PMC
March 2013

Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.

Am J Gastroenterol 2012 Sep 14;107(9):1409-22. Epub 2012 Aug 14.

Division of Gastroenterology, Hospital of the University of Pennsylvania, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2012.218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438468PMC
September 2012

Assessment of variables associated with smoking cessation in Crohn's disease.

Dig Dis Sci 2012 Apr 7;57(4):1026-32. Epub 2012 Feb 7.

Department of Medicine, Division of Gastroenterology, Inflammatory Bowel Disease Clinic, University of Calgary, 3280 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-012-2038-2DOI Listing
April 2012

Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.

Inflamm Bowel Dis 2012 Jan 31;18(1):10-6. Epub 2011 Mar 31.

Inflammatory Bowel Disease Center, University of Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.21707DOI Listing
January 2012

Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine.

Drug Des Devel Ther 2011 Feb 27;5:111-6. Epub 2011 Feb 27.

The Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S5392DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063115PMC
February 2011

The pharmacoeconomics of biologic therapy for IBD.

Authors:
Russell D Cohen

Nat Rev Gastroenterol Hepatol 2010 Feb;7(2):103-9

University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 4076, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2009.232DOI Listing
February 2010

How should we treat severe acute steroid-refractory ulcerative colitis?

Authors:
Russell D Cohen

Inflamm Bowel Dis 2009 Jan;15(1):150-1

Clinical Inflammatory Bowel Disease, University of Chicago Medical Center, MC 4076, 5841 S. Maryland Ave., Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.20776DOI Listing
January 2009

Effects of fistula on healthcare costs and utilization for patients with Crohn's disease treated in a managed care environment.

Inflamm Bowel Dis 2008 Dec;14(12):1707-14

University of Chicago Medical Center, Chicago, Illinois 60657, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.20530DOI Listing
December 2008

What is the optimal maintenance treatment for ulcerative colitis?

Authors:
Russell D Cohen

Inflamm Bowel Dis 2008 Oct;14 Suppl 2:S236-7

Clinical Inflammatory Bowel Disease, Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.20670DOI Listing
October 2008

Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies.

Expert Rev Gastroenterol Hepatol 2007 Oct;1(1):101-12

University of Chicago Hospitals, 5841 S. Maryland Avenue MC 4076, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.1.1.101DOI Listing
October 2007

Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?

Gastrointest Endosc 2007 Jun 23;65(7):998-1004. Epub 2007 Apr 23.

The Reva and David Logan Gastrointestinal Clinical Research Center at the University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gie.2006.09.025DOI Listing
June 2007

Pharmacoeconomics and quality of life of current and emerging biologic therapies for inflammatory bowel disease.

Curr Treat Options Gastroenterol 2007 Jun;10(3):185-94

Russell D. Cohen, MD The University of Chicago Hospitals, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11938-007-0012-4DOI Listing
June 2007

Economics of the use of biologics in the treatment of inflammatory bowel disease.

Gastroenterol Clin North Am 2006 Dec;35(4):867-82

Section of Gastroenterology, Department of Medicine, University of Chicago Medical Center, MC 4076, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gtc.2006.09.004DOI Listing
December 2006

Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement.

Inflamm Bowel Dis 2006 Oct;12(10):972-8

Inflammatory Bowel Disease Center and Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mib.0000231496.92013.85DOI Listing
October 2006

Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.

Inflamm Bowel Dis 2006 Oct;12(10):979-94

Inflammatory Bowel Disease Center and Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mib.0000231495.92013.5eDOI Listing
October 2006

Management of refractory ulcerative colitis.

Curr Treat Options Gastroenterol 2006 Jun;9(3):234-45

Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, MC 4076, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11938-006-0042-3DOI Listing
June 2006

Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.

Am J Gastroenterol 2006 May;101(5):1030-8

Division of Gastroenterology, Department of Medicine, Hospital of The University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2006.00463.xDOI Listing
May 2006

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

Clin Gastroenterol Hepatol 2006 May;4(5):621-30

Department of Medicine, Division of Gastroenterology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2006.03.002DOI Listing
May 2006

MLN-02 in IBD: is "super-selective" really super?

Authors:
Russell D Cohen

Gastroenterology 2006 May;130(6):1923-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2006.01.085DOI Listing
May 2006

Azathioprine versus mesalamine in steroid-dependent ulcerative colitis: long-awaited results?

Authors:
Russell D Cohen

Gastroenterology 2006 Feb;130(2):607-8; discussion 608

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2005.12.042DOI Listing
February 2006

Postoperative management of ulcerative colitis and Crohn's disease.

Curr Gastroenterol Rep 2005 Dec;7(6):492-9

Department of Medicine, Section of Gastroenterology, The University of Chicago Hospitals, 5841 S. Maryland Avenue, MC 4076, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11894-005-0081-2DOI Listing
December 2005

Worms, germs and IBD: is it your mother's fault?

Authors:
Russell D Cohen

Gastroenterology 2005 Sep;129(3):1127-8; discussion 1128-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2005.06.076DOI Listing
September 2005

Mycobacterium in Crohn's: something to ruminate about?

Authors:
Russell D Cohen

Gastroenterology 2005 Jun;128(7):2167-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2005.02.069DOI Listing
June 2005

Mesalamine delivery systems: do they really make much difference?

Adv Drug Deliv Rev 2005 Jan;57(2):281-302

Department of Internal Medicine, Wayne State University, Detroit Medical Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2004.08.008DOI Listing
January 2005

Treating ulcerative colitis without medications--"look mom, no drugs!".

Authors:
Russell D Cohen

Gastroenterology 2005 Jan;128(1):235-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2004.11.024DOI Listing
January 2005

Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease.

Drugs 2004 ;64(16):1767-77

The University of Chicago Medical Center, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003495-200464160-00004DOI Listing
December 2004

Medical therapy for ulcerative colitis: the state of the art and beyond.

Curr Gastroenterol Rep 2004 Dec;6(6):488-95

Department of Medicine, Section of Gastroenterology, The University of Chicago Hospitals, 5841 S. Maryland Avenue, MC 4076, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11894-004-0071-9DOI Listing
December 2004

Sperm, sex, and 6-MP: the perception on conception.

Authors:
Russell D Cohen

Gastroenterology 2004 Oct;127(4):1263-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2004.05.062DOI Listing
October 2004

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.

Gastroenterology 2004 Sep;127(3):723-9

Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2004.06.002DOI Listing
September 2004

Mesalamine in IBD: multiple hats?

Authors:
Russell D Cohen

Gastroenterology 2004 Sep;127(3):1001-2; discussion 1002

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2004.07.029DOI Listing
September 2004

Medical management of severe ulcerative colitis.

Gastroenterol Clin North Am 2004 Jun;33(2):235-50, viii

Section of Gastroenterology, Department of Medicine, The University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gtc.2004.02.005DOI Listing
June 2004

Collagenous gastritis: an unusual association with profound weight loss.

Arch Pathol Lab Med 2004 Feb;128(2):229-32

Lauren V. Ackerman Laboratory of Surgical Pathology, Washington University School of Medicine, St Louis, Mo 63110-1093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2004)128<229:CGAUAW>2.0.CO;2DOI Listing
February 2004

IBD researchers reach for the "tabloid".

Authors:
Russell D Cohen

Gastroenterology 2004 Feb;126(2):611-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2003.09.045DOI Listing
February 2004

Infliximab at 5 years--tweaking the recipe for success?

Authors:
Russell D Cohen

Gastroenterology 2003 Dec;125(6):1902-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2003.06.004DOI Listing
December 2003

Infliximab in ulcerative colitis: is there a placebo (effect) in the house?

Authors:
Russell D Cohen

Gastroenterology 2003 Jun;124(7):1990-1; discussion 1991

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0016-5085(03)00570-5DOI Listing
June 2003

IBD: the drugs work...but do the patients?

Authors:
Russell D Cohen

Am J Gastroenterol 2003 Apr;98(4):722-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2003.07394.xDOI Listing
April 2003

The mesalamine wars heat up-enter balsalazide.

Authors:
Russell D Cohen

Gastroenterology 2003 Feb;124(2):574-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/gast.2003.1240574DOI Listing
February 2003

Evolving medical therapies for ulcerative colitis.

Authors:
Russell D Cohen

Curr Gastroenterol Rep 2002 Dec;4(6):497-505

Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, MC 4076, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11894-002-0026-yDOI Listing
December 2002

Methotrexate in IBD--move over 6-MP? Not so fast...

Authors:
Russell D Cohen

Gastroenterology 2002 Nov;123(5):1737-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/gast.2002.1231737DOI Listing
November 2002

Infliximab decreases resource use among patients with Crohn's disease.

J Clin Gastroenterol 2002 Aug;35(2):151-6

University of Chicago Hospitals, Chicago, Illinois 60637, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004836-200208000-00007DOI Listing
August 2002

Endoscopy of the small bowel in inflammatory bowel disease.

Gastrointest Endosc Clin N Am 2002 Jul;12(3):485-93

University of Washington School of Medicine, 1959 North East Pacific Avenue, Box 356424, University of Washington Medical Center, Division of Gastroenterology, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1052-5157(02)00008-9DOI Listing
July 2002

Crohn's disease and Takayasu's arteritis.

J Clin Gastroenterol 2002 Apr;34(4):454-6

University of Chicago Hospitals, Department of Medicine, Section of Gastroenterology, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004836-200204000-00016DOI Listing
April 2002

Cost utility of initial medical management for Crohn's disease perianal fistula.

Authors:
Russell D Cohen

Gastroenterology 2002 Apr;122(4):1187-8; author reply 1188-90

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/gast.2002.32782DOI Listing
April 2002

Endoscopy in inflammatory bowel disease.

Gastroenterol Clin North Am 2002 Mar;31(1):119-32

Department of Medicine, Division of Gastroenterology, University of Washington Medical Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0889-8553(01)00008-5DOI Listing
March 2002

Infliximab as first-line therapy for severe Crohn's disease?

Authors:
Russell D Cohen

Inflamm Bowel Dis 2002 Jan;8(1):58-9; discussion 63-5

Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00054725-200201000-00010DOI Listing
January 2002